Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study

Abstract

ObjectiveDrug shortages were a complex global problem. The aim of this study was to analyze, characterize, and assess the drug shortages, and identify possible solutions in Shaanxi Province, western China.MethodsA qualitative methodological approach was conducted during May–June 2015 and December 2015–January 2016. Semi-structured interviews were performed to gather information from representatives of hospital pharmacists, wholesalers, pharmaceutical producers, and local health authorities.ResultsThirty participants took part in the study. Eight traditional Chinese medicines and 87 types of biologicals and chemicals were reported to be in short supply. Most were essential medicines. Five main determinants of drug shortages were detected: too low prices, too low market demands, Good Manufacturing Practice (GMP) issues, materials issues, and approval issues for imported drugs. Five different solutions were proposed by the participants: 1) let the market decide the drug price; 2) establish an information platform; 3) establish a reserve system; 4) enhance the communication among the three parties in the supply chain; and 5) improve hospital inventory management.ConclusionsWestern China was currently experiencing a serious drug shortage. Numerous reasons for the shortage were identified. Most drug shortages in China were currently because of “too low prices.” To solve this problem, all of the stakeholders, especially the government, needed to participate in managing the drug shortages.

The effect of the implementation of low price medicine policy on medicine price in China: A retrospective study

“…This might be consistent with the viewpoint that "a higher price but available in the market" benefited patients more than "a lower price but no access". 13 The increase in the supply could meet the patients' need for treatment of the disease. Studies about LPM indicated that when government increased the price-cap, or loosed price regulation, the medicine's price would rise.…”

“…11 Medicine shortage is a critical worldwide problem, 12 and China is no exception. 13 In 2011, Protamine was in short supply in China, which seriously affected the ability to perform extracorporeal circulation operations for heart diseases. 14 Methimazole, Pralidoxime chloride, and Noradrenaline were reported shortages in some areas.…”

Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications

“…Over the years, the shortage of medicines has been a challenge to the effective delivery of quality healthcare services worldwide including South Africa [1][2][3][4][5][6][7][8][9][10], with shortages of even essential medicines becoming a global problem irrespective of the economic status of countries [11][12][13]. More than half of the world's population do not have access to essential services [14], exacerbated by medicine shortages.…”

Ensuring universal access to old antibiotics: a critical but neglected priority

“…A European survey conducted among more than 600 hospital pharmacists from 36 countries reported that antimicrobials were the most affected therapeutics [6]. Causes for these shortages are multiple and complex, including failures in manufacturing processes, scarcity of raw materials, concentration of manufacturing in emerging economies, pressure on profit margins, and sometimes dependence on a single producer [7]. No studies have been conducted to assess the exact consequences of antibiotic shortages on patients' outcomes, but national agencies reported that some patients experienced negative outcomes because of a less effective or more toxic alternative.…”